First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expandin......